Delivery Order SPE2DR25D3005-SPE2DR26FP8ZY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,962.71 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count) on January 6, 2026, with a contract ceiling value of $5,823.04 and an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.93 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,521.98 delivery order on December 4, 2025, for the supply of Isotretinoin 40 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 5, 2025, and performance to be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract ceiling value of $1,300.24. This competitively awarded, non-set-aside delivery order utilizes firm fixed-price pricing and is scheduled for completion by January 29, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,283.59 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packages) on January 21, 2026, with completion targeted for January 22, 2026. This firm fixed-price, non-set-aside contract will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 26, 2026, for Isotretinoin 30 mg capsules with a ceiling value of $2,969.01. This non-set-aside, firm fixed-price delivery order is scheduled for completion by January 27, 2026, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,696.96 to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (10-count units) on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,744.67 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Isotretinoin 40 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of January 8, 2026, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's parent company Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at $6,969.33 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) with a firm fixed price contract type. The contract was competitively awarded without a set-aside designation and is scheduled for completion by April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver this pharmaceutical product to...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8ZYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,377.62 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 28, 2026, with an ultimate completion date of January 29, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the AmerisourceBergen brand), is a major pharmaceutical distributor and critical federal vendor specializing in supplying a comprehensive range of medications, vaccines, and medical supplies to military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill complex medical procurement requirements across multiple therapeutic domains, and this particular delivery order for Isotretinoin—a prescription medication used primarily for severe acne treatment—reflects the company's ongoing role as a key supplier within the DLA's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/27/26 |